angiotensin ii has been researched along with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Gordillo-Moscoso, A; Padilla, E; Redondo, S; Ruiz, E; Tejerina, T | 1 |
Banfalvi, A; Borok, Z; Buckley, ST; Crandall, ED; DeMaio, L; Dubourd, M; Ehrhardt, C; Flodby, P; Krishnaveni, MS; Minoo, P; Xing, Y; Zhou, B | 1 |
Chou, CH; Chuang, LY; Guh, JY; Lu, CY | 1 |
Ahıshalı, B; Akcan, U; Altunsu, D; Atis, M; Ayvaz, E; Girouard, H; Kaya, M; Sarıkaya, D; Temizyürek, A; Uğur Yılmaz, C | 1 |
4 other study(ies) available for angiotensin ii and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide
Article | Year |
---|---|
Role of TGF-beta1 in vascular smooth muscle cell apoptosis induced by angiotensin II.
Topics: Activin Receptors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzamides; Biphenyl Compounds; Cell Proliferation; Cells, Cultured; Dioxoles; Irbesartan; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Inbred WKY; Tetrazoles; Transforming Growth Factor beta1 | 2007 |
Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.
Topics: Actins; Alveolar Epithelial Cells; Angiotensin II; Animals; Antibiotics, Antineoplastic; Benzamides; Bleomycin; Cells, Cultured; Collagen Type I; Dioxoles; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Ligands; Male; Mice; Mice, Knockout; Protein Serine-Threonine Kinases; Pulmonary Fibrosis; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Vimentin | 2012 |
Interaction between TGF-β and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Benzamides; Cells, Cultured; Chromones; Dioxoles; Fibronectins; Gene Expression Regulation; Glucose; Janus Kinase 2; LLC-PK1 Cells; Molecular Sequence Data; Morpholines; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, G-Protein-Coupled; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction; Swine; Transcription, Genetic; Transforming Growth Factor beta; Tyrphostins | 2013 |
Targeting the blood-brain barrier disruption in hypertension by ALK5/TGF-Β type I receptor inhibitor SB-431542 and dynamin inhibitor dynasore.
Topics: Albumins; Angiotensin II; Animals; Benzamides; Blood-Brain Barrier; Claudin-5; Dioxoles; Dynamins; Hydrazones; Hypertension; Mice; Receptor, Transforming Growth Factor-beta Type I; Transforming Growth Factor beta | 2022 |